{"id":"W4381191604","doi":"10.7573/dic.2023-4-1","title":"Real-world experience of cabozantinib in Asian patients with advanced renal cell carcinoma following treatment with VEGFR tyrosine kinase inhibitors and/or immune checkpoint inhibitors","year":2023,"lang":"en","type":"article","venue":"Drugs in Context","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Ipsen","keywords":"Cabozantinib; Medicine; Renal cell carcinoma; Clinical endpoint; Oncology; Nivolumab; Internal medicine; Pazopanib; Adverse effect; Population; Cancer; Clinical trial; Sunitinib; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001313055,0.0001938187,0.0003427041,0.0001419958,0.0005293218,0.0006249559,0.0002475789,0.0002831346,0.0009325422],"category_scores_gemma":[0.002496051,0.0001122142,0.0003349316,0.0003396198,0.0004164663,0.0003491348,0.0004892666,0.0005319387,0.0002287556],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008520688,"about_ca_system_score_gemma":0.0007262421,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0029754,"about_ca_topic_score_gemma":0.004380175,"domain_scores_codex":[0.9993648,0.0003107638,0.00007149851,0.00006414075,0.00009836908,0.00009037224],"domain_scores_gemma":[0.9978485,0.0004164678,0.0008626204,0.0000868142,0.0002362532,0.0005493695],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003544321,0.001532629,0.9239392,0.0003371103,0.0003345062,0.01179831,0.005756961,0.0009702668,0.004463482,0.0001598636,0.001666451,0.04549696],"study_design_scores_gemma":[0.0009134583,0.01672416,0.8985786,0.0001849524,0.0007788168,0.04595251,0.008023418,0.002674887,0.004392699,0.0002264937,0.02144087,0.0001090345],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9981596,0.0006412728,0.0001368925,0.0001676189,0.000008017433,0.00002111231,0.00005729029,0.000004455821,0.0008037378],"genre_scores_gemma":[0.9989423,0.0004434244,0.0001485362,0.0002073798,0.00001962995,0.00001220553,0.00008715936,0.000002661253,0.0001367247],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0029754,"threshold_uncertainty_score":0.006944239,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01315660330541851,"score_gpt":0.2568507259529053,"score_spread":0.2436941226474868,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}